The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...
20h
Assenagon Asset Management S.A. raised its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 12.4% during the 4th quarter, HoldingsChannel reports. The fund owned 238,522 shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback